7.3 Exercise Contraindications, Adverse Signs/Symptoms & Emergency Protocols
Key Takeaways
- Absolute contraindications to exercise—such as unstable angina within 48 hours, decompensated heart failure, severe symptomatic aortic stenosis, acute pulmonary embolism, and dissecting aneurysm—mandate withholding exercise until complete medical stabilization.
- In-session exercise must be terminated immediately for adverse signs and symptoms including moderate-to-severe angina (>= 2 on 1–4 scale), sustained drop in SBP > 10 mmHg with increasing workload, exertional SBP > 220–250 mmHg, CNS symptoms, or complex ventricular arrhythmias.
- Supplemental oxygen is clinically indicated during acute exertional distress only when oxygen saturation (SpO2) drops below 90% to 92%, as hyperoxia in normoxemic patients causes paradoxical coronary vasoconstriction and increased oxidative stress.
- Sublingual nitroglycerin (0.4 mg every 5 minutes up to 3 doses) requires a baseline SBP >= 90–100 mmHg and is strictly contraindicated within 24 hours of sildenafil/vardenafil or 48 hours of tadalafil use due to life-threatening, refractory hypotension.
- In an acute chest pain emergency, staff must stop exercise, place the patient in a seated or recumbent position, record a 12-lead ECG, verify vitals, assess contraindications prior to nitroglycerin, and activate emergency medical response if symptoms fail to resolve after the first dose.
7.3 Exercise Contraindications, Adverse Signs/Symptoms & Emergency Protocols
Patient safety in cardiac rehabilitation depends on rigorous pre-exercise screening, continuous clinical monitoring, and prompt execution of emergency protocols. Because cardiac rehabilitation cohorts include individuals with advanced ischemic heart disease, heart failure, and arrhythmias, clinicians must rapidly recognize contraindications, adverse exertional responses, and acute emergencies.
Absolute vs. Relative Contraindications to Exercise
Before clearing any patient for exercise, clinical staff must evaluate baseline clinical stability:
Absolute Contraindications (Exercise Strictly Prohibited)
In the presence of an absolute contraindication, exercise testing and training must be withheld until the condition is medically evaluated and stabilized:
- Unstable Angina: New-onset severe angina, resting angina, or accelerating angina within the preceding 48 hours.
- Acute Decompensated Heart Failure: Resting dyspnea, orthopnea, new S3 gallop, bilateral pulmonary crackles, jugular venous distention, or rapid fluid weight gain ( in 48 to 72 hours).
- Uncontrolled Lethal Arrhythmias: Sustained ventricular tachycardia, rapid atrial fibrillation with uncontrolled ventricular response ( at rest), or symptomatic high-grade ventricular ectopy.
- Severe Symptomatic Aortic Stenosis: Mean gradient or valve area with exertional angina, syncope, or dyspnea. Fixed outflow obstruction prevents cardiac output from rising, risking exertional collapse or sudden death.
- Acute Pulmonary Embolism or Acute DVT: Until therapeutic anticoagulation is established ( hours) and symptoms stabilize.
- Acute Myocarditis or Acute Pericarditis: Active inflammation creates electrical instability, predisposing to fatal arrhythmias.
- Acute Aortic Dissection: Known or suspected thoracic or abdominal dissecting aneurysm.
- Acute Systemic Infection: Febrile illness or severe infection accompanied by resting tachycardia.
Relative Contraindications (Requires Medical Review & Modification)
Exercise may proceed only after physician consultation, weighing benefits against risks, with conservative workloads and continuous monitoring:
- Left Main Coronary Stenosis: Severe unbypassed/unrevascularized stenosis ().
- Moderate Stenotic Valvular Disease: Moderate aortic stenosis (valve area ) or severe asymptomatic aortic stenosis.
- Resting Severe Hypertension: Resting SBP or resting DBP . Have the patient rest quietly for 15 minutes; if blood pressure remains above these thresholds, withhold exercise and consult the physician.
- High-Degree Atrioventricular Block: Mobitz Type II second-degree AV block or complete third-degree AV block without a functioning permanent pacemaker.
- Hypertrophic Obstructive Cardiomyopathy (HOCM): With severe dynamic resting outflow tract gradients.
- Severe Tachycardia or Bradycardia: Resting HR or symptomatic bradycardia .
- Uncontrolled Metabolic Disease: Severe diabetic ketoacidosis, hyperosmolar state, or blood glucose with ketones.
Exercise Contraindications Classification Table
| Classification | Clinical Condition | Pathophysiologic Hazard | Mandatory Staff Action |
|---|---|---|---|
| Absolute | Unstable Angina (<48h) | Plaque rupture; imminent transmural MI | Withhold exercise; transfer for emergency ACS workup |
| Absolute | Decompensated Heart Failure | Pulmonary congestion; cardiogenic shock | Withhold exercise; urgent physician referral for diuresis |
| Absolute | Severe Symptomatic Aortic Stenosis | Fixed outflow obstruction; syncope/sudden death | Withhold exercise; urgent surgical/TAVR evaluation |
| Absolute | Acute Pulmonary Embolism / DVT | Thrombus propagation; acute cor pulmonale | Withhold exercise until therapeutic anticoagulation $\ge 24$–48h |
| Absolute | Acute Myocarditis or Pericarditis | Myocardial electrical instability; arrhythmias | Strict exercise prohibition for 3 to 6 months |
| Relative | Unbypassed Left Main Stenosis $\ge 50%$ | Extensive anterior wall ischemia | Physician clearance; low-intensity monitored exercise |
| Relative | Resting BP >200/110 mmHg | Exertional intracranial hemorrhage / LV strain | Rest 15 min; recheck; withhold if persistently elevated |
| Relative | Mobitz II or 3rd-Degree AV Block | Progression to ventricular asystole | Withhold until permanent pacemaker implantation |
| Relative | Hypertrophic Obstructive Cardiomyopathy | Outflow tract gradient surge | Individualized low-intensity; avoid Valsalva/hypovolemia |
In-Session Exercise Termination Criteria
Exercise must be stopped immediately if any of the following physiological criteria occur:
Subjective Symptoms
- Moderate-to-Severe Angina: Angina scale rating on a 1 to 4 scale (2 = moderate/bothersome, 3 = severe/intense, 4 = excruciating).
- Excessive Dyspnea: Dyspnea scale rating on a 1 to 4 scale, or severe breathlessness disproportionate to workload.
- Central Nervous System Symptoms: Dizziness, lightheadedness, ataxia, confusion, or impending syncope (cerebral hypoperfusion).
- Signs of Hypoperfusion: Pallor, cold clammy diaphoresis, or peripheral cyanosis.
- Patient Request: The patient's request to stop exercise must always be honored immediately.
Objective Hemodynamic & Electrocardiographic Criteria
- Drop in Systolic Blood Pressure: Sustained drop in SBP of below baseline, or a drop in SBP with increasing workload, particularly when accompanied by other ischemic signs (indicates acute left ventricular dysfunction or severe multivessel disease).
- Excessive Hypertensive Response: Exertional SBP or DBP **.
- ST-Segment Displacement: Horizontal or downsloping ST depression () measured 80 ms past the J-point, or ST elevation in non-infarction leads.
- Complex Arrhythmias: Sustained or non-sustained ventricular tachycardia ( consecutive PVCs), multifocal PVCs, frequent paired PVCs, rapid supraventricular tachycardias, or onset of high-degree AV block (Mobitz II or complete heart block).
Acute Emergency Protocols & Nitroglycerin Safety
Cardiac rehabilitation facilities must maintain emergency crash carts with biphasic defibrillators, oxygen, ACLS medications, and established emergency algorithms.
Chest Pain Emergency Algorithm
- Stop Exercise & Position Safely: Terminate exercise immediately. Assist the patient into a seated or semi-Fowler's position. Never leave the patient unattended.
- Vital Signs & Diagnostic ECG: Obtain blood pressure, heart rate, pulse oximetry (), and record an immediate 12-lead ECG to evaluate for ST-elevation MI or ischemic patterns.
- Evidence-Based Oxygen Therapy: Administer supplemental oxygen (2 to 4 L/min via nasal cannula) only if hypoxemic () or in respiratory distress. Routine oxygen in normoxemic patients causes coronary vasoconstriction and increased oxidative injury.
- Sublingual Nitroglycerin (SL NTG) Protocol:
- Verify baseline SBP is **.
- MANDATORY PDE-5 Inhibitor Screening: Question patient regarding recent use of phosphodiesterase type 5 inhibitors:
- Sildenafil or Vardenafil: Withhold nitrates if taken within 24 hours.
- Tadalafil: Withhold nitrates if taken within 48 hours (due to 17.5-hour half-life).
- Combining nitrates with PDE-5 inhibitors causes massive cyclic GMP accumulation, severe refractory vasodilation, and fatal hypotension. Nitrates are also contraindicated in suspected right ventricular infarction or severe aortic stenosis due to acute preload failure.
- Dosing: Administer one 0.4 mg SL NTG tablet or metered spray while seated. Recheck blood pressure, heart rate, and pain every 5 minutes. If pain persists and SBP remains , repeat 0.4 mg every 5 minutes up to 3 total doses over 15 minutes.
- Code Activation: If symptoms fail to resolve after the first dose in an outpatient setting, or if hemodynamic instability or STEMI develops, activate Code Blue or 911 immediately. Prepare the defibrillator, administer chewable aspirin (162 to 325 mg), and establish IV access.
Clinical Emergency Scenario: In-Session Exertional Ischemia
Clinical Scenario: A 63-year-old male with prior anterior MI is walking on the treadmill at 3.2 mph and 4% grade. At minute 14, he clutches his chest (Levine's sign) reporting 3/4 crushing retrosternal pressure. Telemetry shows 2.5 mm horizontal ST depression and frequent PVCs.
Protocol Execution:
- Immediate Action: Stop treadmill immediately; assist patient to a seated armchair.
- Initial Assessment: BP is 108/68 mmHg, HR 118 bpm, 95% on room air. Because , oxygen is withheld.
- Medication Screening: Staff confirms no PDE-5 inhibitor use in the past 48 hours. SBP is confirmed .
- Therapy: Administer 0.4 mg sublingual nitroglycerin tablet; order STAT 12-lead ECG.
- Re-Check: At minute 5, chest pain decreases to 1/4, BP is 98/64 mmHg, and ST depression resolves to 0.5 mm. Staff contact the supervising physician, cancel exercise, and transfer the patient for urgent catheterization.
A 67-year-old female with known coronary artery disease presents for her scheduled Phase II cardiac rehabilitation session. During the pre-exercise intake assessment, she reports increasing shortness of breath when lying flat, a 6-pound weight gain over the last 3 days, and bilateral pitting ankle edema. Auscultation reveals inspiratory bibasilar crackles and a prominent third heart sound (S3). According to AACVPR guidelines, what is the clinical classification of these findings and the mandatory staff action?
During a Phase II cardiac rehabilitation session, a 58-year-old male with a history of coronary artery bypass grafting is walking on the treadmill. At minute 8, his systolic blood pressure drops from an initial resting level of 134 mmHg down to 118 mmHg despite an increase in treadmill speed and grade. The patient also complains of lightheadedness, and telemetry reveals 2 mm of horizontal ST depression. What does this hemodynamic response indicate, and what is the required clinical action?
A 61-year-old male on telemetry in cardiac rehabilitation reports sudden substernal chest tightness (rated 2/4 on the angina scale) radiating to his left shoulder while using a stationary cycle. Staff immediately stop exercise and seat the patient. Vital signs reveal a blood pressure of 124/76 mmHg, heart rate of 88 bpm, and oxygen saturation (SpO2) of 96% on room air. Before administering sublingual nitroglycerin, what mandatory medication screening question must staff ask, and what is the rule regarding supplemental oxygen?
A patient in cardiac rehabilitation develops acute substernal chest discomfort rated 3/4. The patient is seated, vital signs are obtained (BP 116/74 mmHg, HR 82 bpm, SpO2 94%), and PDE-5 inhibitors are ruled out. Staff administer one 0.4 mg sublingual nitroglycerin tablet. At the 5-minute reassessment, the patient states the chest pressure remains unchanged at 3/4, and repeat blood pressure is 108/70 mmHg. What is the correct next step in the clinical emergency protocol?